Notable Movers: Nokia Corporation (ADR) (NYSE:NOK), Facebook Inc (NASDAQ:FB), Zynga Inc (NASDAQ:ZNGA), Sirius XM Holdings Inc. (NASDAQ:SIRI), Netflix, Inc. (NASDAQ:NFLX)
Nokia and Airtel have teamed up to offer free download of Android apps on the Nokia XL for six months. With this Airtel plan, Nokia XL user can avail of up to 500MB of free usage, allowing them to download their favourite apps from the Nokia store and 1Mobile store. Nokia Corporation (ADR) (NYSE:NOK) stock finished the day at $8.04. Traded volume was 10.73million shares in the last … Continue reading Notable Movers: Nokia Corporation (ADR) (NYSE:NOK), Facebook Inc (NASDAQ:FB), Zynga Inc (NASDAQ:ZNGA), Sirius XM Holdings Inc. (NASDAQ:SIRI), Netflix, Inc. (NASDAQ:NFLX)
Hot Watch List: Sony (NYSE:SNE), Advanced Micro Devices, Inc. (NYSE:AMD), NVIDIA Corporation (NASDAQ:NVDA), Spanish Broadcasting System (NASDAQ:SBSA), Saga Communications (NYSEMKT:SGA)
Oculus and Sony Corp (ADR) (NYSE:SNE) are expected to begin selling their devices next year, but content remains scarce. At E3, Playful Corp debuted adventure game “Lucky’s Tale” and CCP Games presented space combat game “Valkyrie.” Sony Corp (ADR) (NYSE:SNE) stock performance was 0.81% in last session and finished the day at $16.22. Traded volume was 2.51million shares in the last session and the average … Continue reading Hot Watch List: Sony (NYSE:SNE), Advanced Micro Devices, Inc. (NYSE:AMD), NVIDIA Corporation (NASDAQ:NVDA), Spanish Broadcasting System (NASDAQ:SBSA), Saga Communications (NYSEMKT:SGA)
Hot Watch List: Teva Pharmaceutical Industries (NYSE:TEVA), Vodafone Group (NASDAQ:VOD), VIVUS (NASDAQ:VVUS), ConocoPhillips (NYSE:COP), BP plc (ADR) (NYSE:BP)
Teva Pharmaceutical Industries Ltd. (ADR) (NYSE:TEVA) announced that the U.S. Court of Appeals for the Federal Circuit today upheld a ruling by the U.S. District Court for the District of Delaware finding Bristol-Myers Squibb’s entecavir compound claim of U.S. Patent No. 5,206,244 invalid. Teva’s ANDA for entecavir has received tentative approval from the U.S. Food and Drug Administration (FDA). Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) … Continue reading Hot Watch List: Teva Pharmaceutical Industries (NYSE:TEVA), Vodafone Group (NASDAQ:VOD), VIVUS (NASDAQ:VVUS), ConocoPhillips (NYSE:COP), BP plc (ADR) (NYSE:BP)
Solar Stocks on the move: Sunedison Inc (NYSE:SUNE), Yingli Green Energy (NYSE:YGE), Trina Solar (NYSE:TSL), Canadian Solar Inc. (NASDAQ:CSIQ), Suntech Power (OTCMKTS:STPFQ)
SunEdison, Inc. (NYSE:SUNE), announced today that, at its May 29, 2014 Annual Meeting, its stockholders voted to approve an amendment to the Company’s Amended and Restated Certificate of Incorporation to increase the number of the Company’s authorized shares of common stock issuable from 300,000,000 to 700,000,000. The increase in authorized shares of common stock will allow the Company to satisfy issuances under future equity-based awards … Continue reading Solar Stocks on the move: Sunedison Inc (NYSE:SUNE), Yingli Green Energy (NYSE:YGE), Trina Solar (NYSE:TSL), Canadian Solar Inc. (NASDAQ:CSIQ), Suntech Power (OTCMKTS:STPFQ)
(Video) Alstom (ALO.PA) Takeover Crucial Week for General Electric (NYSE:GE) Siemens (SIE:Xetra) and Mitsubishi (8058:JP)
France is continuing to press for guarantees from contenders to buy energy assets from Alstom, as Siemens and Mitsubishi consider a joint move to challenge a formal offer from General Electric. The race to acquire power activities from Alstom, better known for its high-speed TGV trains, is entering a crucial week, with Siemens due to present an offer by Monday ahead of a June 23 cut-off date set by GE for its 12.4 billion euros bid for all of Alstom’s energy assets.
As a consequence of this latest move, GE May Improve Bid for Alstom’s Energy Units. French Finance Minister Michel Sapin said he expects General Electric Co. (GE) may improve its $17 billion offer as it competes with Siemens AG (SIE) to buy energy assets of power-equipment maker Alstom SA. “We’re not finished with improvements, on both sides,” Sapin said today on Europe 1 radio and i-Tele. Siemens’s offer becomes more attractive with Mitsubishi Heavy Industries Ltd. (7011) participating, he also said.
According to a Wall Street Journal report on Sunday, German engineering company Siemens and Japanese peer Mitsubishi Heavy Industries were close on Sunday to finalizing an offer for much of Alstom’s energy business, potentially entering a bidding war with General Electric for one of France’s industrial jewels, said people familiar with the companies’ plans. As part of the potential offer, Mitsubishi aims to buy as much as 10% of Alstom from Bouygues which holds a 29.3% stake, two of the people said. French public investment bank BPI France would buy another portion of the Bouygues stake, possibly alongside the French government, these people said. Talks were continuing late Sunday in Europe, these people said, and the final structure of the deal wasn’t set.
BioTech Stock News in Video : Valeant (NYSE:VRX) vs Allergan (NYSE:AGN) Takeover Battle, Medtronic (NYSE:MDT) + Covidien (NYSE:COV) $45 Billion Deal in Video + GMO Experiments
A source familiar with the matter said on Saturday, Medical-device maker Medtronic Inc and rival Covidien, are in advanced talks to combine in a deal valued at $45 billion to $50 billion. The person said, asking not to be named because the matter is not public, the deal, which would allow Medtronic to be domiciled in Ireland where Covidien is based and thus take advantage of lower tax rates, could come as soon as Monday. Minneapolis-based Medtronic, which makes cardiovascular and orthopedic devices, has a market value of about $61 billion.
An executive vice-president of Valeant Pharmaceuticals International Inc will leave the company, even as the Canadian drugmaker fends off criticism about management turnover from its takeover target Allergan Inc . Valeant confirmed late on Friday after inquiries by Reuters, Executive vice-president and company group chairman Ryan Weldon will leave. Like Chief Executive Mike Pearson, Weldon previously worked for management consulting firm McKinsey & Co. Valeant said Weldon’s departure was planned, and takes effect after it completes a $1.4 billion sale of several injectable treatments to Nestle SA.
Before residents in southern Oregon overwhelmingly voted to ban genetically modified crops last month, farmers negotiated for months with a biotech company that grows engineered sugar beets near their fields. Their goal was to set up a system to peacefully coexist, an online mapping database of fields to help growers minimize cross-pollination between engineered and non-engineered crops. But the effort between farmers and Swiss company Syngenta failed, leading to the ban. Last October, Oregon Gov. John Kitzhaber directed the state’s Department of Agriculture to undertake something far more ambitious than that failed mapping effort — map GMO field locations across the entire state and establish buffer zones and exclusion areas for GE crops.
